Blog

Nico Gagelmann: Big achievement in JCO on timing of transplantation for patients with MDS

Nico Gagelmann/X

May 12, 2024, 04:15

Nico Gagelmann: Big achievement in JCO on timing of transplantation for patients with MDS

Nico Gagelmann, shared on LinkedIn

“Finally out!

Huge congratulations to Matteo G Della Porta and all contributors to this big achievement in JCO on timing of transplantation for patients with MDS.

These results provide evidence for the clinical relevance of including genomic features into the transplantation decision making process, allowing personalizing the hazards and effectiveness of HSCT in patients with MDS.”

Nico Gagelmann
OncoDaily

Read the article.
Source: Nico Gagelmann/LinkedIn

cancer cancer treatment Genomic Features hematopoietic stem cell transplantation HSCT JCO Journal of Clinical Oncology Matteo G Della Porta MDS Medical Research myelodysplastic syndromes Nico Gagelmann OncoDaily Oncology personalized medicine Transplant Timing

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage